Little Green Pharma (ASX:LGP) Equity-to-Asset

: 0.87 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Little Green Pharma's Total Stockholders Equity for the quarter that ended in Sep. 2023 was A$80.70 Mil. Little Green Pharma's Total Assets for the quarter that ended in Sep. 2023 was A$92.91 Mil. Therefore, Little Green Pharma's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.87.

The historical rank and industry rank for Little Green Pharma's Equity-to-Asset or its related term are showing as below:

ASX:LGP' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.75 Med: 0.83 Max: 0.87
Current: 0.87

During the past 4 years, the highest Equity to Asset Ratio of Little Green Pharma was 0.87. The lowest was 0.75. And the median was 0.83.

ASX:LGP's Equity-to-Asset is ranked better than
90.8% of 1087 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs ASX:LGP: 0.87

Little Green Pharma Equity-to-Asset Historical Data

The historical data trend for Little Green Pharma's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

Equity-to-Asset

0.90

0.75

0.85

0.83

Little Green Pharma Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23
Equity-to-Asset		0.81	0.85	0.83	0.83	0.87

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma Equity-to-Asset Distribution

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's Equity-to-Asset falls into.

Little Green Pharma Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Little Green Pharma's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	82.228	/	98.62
	=	0.83

Little Green Pharma's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	80.695	/	92.909
	=	0.87

Little Green Pharma (ASX:LGP) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Little Green Pharma Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Little Green Pharma (ASX:LGP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines